Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUGAR-DM-HF: Empagliflozin in Heart Failure and Diabetes
NCT03485092Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in heart failure (HF), sponsored by NHS Greater Glasgow and Clyde. Started Mar 2018; status: completed.
02
Drugs
empagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03485092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485092.